XML 22 R14.htm IDEA: XBRL DOCUMENT v3.26.1
Balance sheet components
3 Months Ended
Mar. 31, 2026
Balance sheet components  
Balance sheet components

5. Balance sheet components

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

March 31, 2026

 

 

December 31, 2025

 

Clinical development expenses

 

$

9,363

 

 

$

7,036

 

Manufacturing expenses

 

 

5,286

 

 

 

9,462

 

Compensation and related benefits

 

 

3,068

 

 

 

11,527

 

Development milestones

 

 

986

 

 

 

10,000

 

Other

 

 

3,175

 

 

 

3,626

 

Total accrued expenses and other current liabilities

 

$

21,878

 

 

$

41,651